GREENLAND MINES LTD Increase (Decrease) in Accounts Payable, Related Parties
GREENLAND MINES LTD (GRML) reported Increase (Decrease) in Accounts Payable, Related Parties of -$31.00 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-18.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties · last filed 2025-08-18
- GREENLAND MINES LTD increase (decrease) in accounts payable, related parties for the quarter ending 2025-06-30 was $0.00.
- GREENLAND MINES LTD increase (decrease) in accounts payable, related parties for the quarter ending 2025-03-31 was -$31.00K, a 162.00% decline year-over-year.
- GREENLAND MINES LTD increase (decrease) in accounts payable, related parties for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- GREENLAND MINES LTD increase (decrease) in accounts payable, related parties for the quarter ending 2024-09-30 was $0.00.
- GREENLAND MINES LTD increase (decrease) in accounts payable, related parties for fiscal 2024 was -$128.00K, a 180.50% decline from fiscal 2023.
- GREENLAND MINES LTD increase (decrease) in accounts payable, related parties for fiscal 2023 was $159.00K.
| Period end | Increase (Decrease) in Accounts Payable, Related Parties 3 month | Increase (Decrease) in Accounts Payable, Related Parties 6 month | Increase (Decrease) in Accounts Payable, Related Parties 9 month | Increase (Decrease) in Accounts Payable, Related Parties 12 month |
|---|---|---|---|---|
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-18 | -$31.00K 10-Q · filed 2025-08-18 | -$31.00K derived: sum of 3 quarters · filed 2025-08-18 | -$31.00K derived: sum of 4 quarters · filed 2025-08-18 |
| 2025-03-31 | -$31.00K 10-Q · filed 2025-05-15 | -$31.00K derived: sum of 2 quarters · filed 2025-05-15 | -$31.00K derived: sum of 3 quarters · filed 2025-05-15 | -$209.00K derived: sum of 4 quarters · filed 2025-08-18 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | -$178.00K derived: sum of 3 quarters · filed 2025-08-18 | -$128.00K 10-K · filed 2025-03-31 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-19 | -$178.00K derived: sum of 2 quarters · filed 2025-08-18 | -$128.00K 10-Q · filed 2024-11-19 | -$14.00K derived: sum of 4 quarters · filed 2025-08-18 |
| 2024-06-30 | -$178.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-18 | -$128.00K 10-Q · filed 2025-08-18 | -$14.00K derived: sum of 3 quarters · filed 2025-08-18 | |
| 2024-03-31 | $50.00K 10-Q · filed 2025-05-15 | $164.00K derived: sum of 2 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $114.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $159.00K 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $45.00K 10-Q · filed 2024-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |